3 ·Filed Jul 10, 2026
Form 3 — initial insider ownership statement
Actionable Insight • Neutral
Monitor future Form 4 filings from McDonnell for any open-market purchases or sales, which would provide a clearer signal on insider conviction. No immediate trading implications from this filing alone.
Latest settled — T+20d
MRNA ▼ -10.74% at T+20d
NEUTRAL call ✗ call lost -10.74% · α vs SPY -13.93% · entry $67.01 → $59.81
Latest observation: T+56 +83.46% FF3 residual α
T+1d
+0.64%
call +0.64% · α +0.29%
$67.44
settled 3mo ago
T+5d
-7.75%
call -7.75% · α -6.96%
$61.82
settled 3mo ago
T+20d
-10.74%
call -10.74% · α -13.93%
$59.81
settled 8w ago
T+60d
—
call — · α —
—
in 3d
Price Chart
Loading chart...
Executive Summary
Michael McDonnell filed a Form 3 initial statement of beneficial ownership with Moderna, indicating he has become an officer or director. The filing is a routine administrative requirement and contains no transaction or holding details.
Key Facts
- Form 3 filed by Michael McDonnell as a new reporting person at Moderna.
- No securities holdings or transactions disclosed in the filing.
- Power of attorney executed on July 8, 2026, authorizing officers to file Section 16 forms.
Financial Impact
No financial impact; routine insider onboarding filing.
Risk Factors
- No material risks identified from this administrative filing.
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
13% bullish (30 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001682852-26-000137 |
| Document: 0001682852-26-000137-index-headers.html | 0001682852-26-000137 |
| Document: 0001682852-26-000137-index.html | 0001682852-26-000137 |
| Document: 0001682852-26-000137.txt | 0001682852-26-000137 |
18 reports for MRNA
80% Hit rate best @ T+60▲ +14.15%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 30, 2026 2d ago | ANALYST-DOWNGRADE | — | awaiting T+5 | — | — |
Sep 3, 2026 29d ago | ANALYST-DOWNGRADE | $148.87 $143.97 | ▲ +3.29% | ▲ +2.14% | $190.01 (−27.63%) |
Aug 31, 2026 4w ago | Court Ruling | $140.19 $140.33 | ▼ −0.10% | ▼ −0.24% | $190.01 (−35.54%) |
Aug 25, 2026 5w ago | ANALYST-UPGRADE | $158.83 $154.27 | ▼ −2.87% | ▼ −2.33% | $190.01 (+19.63%) |
Aug 19, 2026 6w ago | ANALYST-UPGRADE | $174.38 $149.66 | ▼ −14.18% | ▼ −13.79% | $190.01 (+8.96%) |
Aug 5, 2026 8w ago | 144 | $56.26 $63.67 | ▼ −13.18% | ▼ −12.83% | $190.01 (−237.77%) |
Jul 31, 2026 9w ago | 8-K | $54.82 $59.17 | ▲ +7.94% | ▲ +4.42% | $190.01 (+246.61%) |
Jul 10, 2026 11w ago | 3 | $67.01 $61.82 | ▼ −7.75% | ▼ −6.96% | $190.01 (+183.55%) |
Jul 8, 2026 12w ago | 8-K | $73.80 $67.44 | ▼ −8.62% | ▼ −9.48% | $190.01 (+157.47%) |
Jun 18, 2026 15w ago | 144 | $63.96 $59.75 | ▼ −6.58% | ▼ −4.92% | $190.01 (+197.08%) |
Showing 10 of 18
US Market Status
Market Closed — Opens Mon (65h 1m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access